World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
35594
World Ranking
13467
National Ranking
6847

Research.com Recognitions

  • 2015 - Fellow of the American Statistical Association (ASA)

Overview

Susan Halabi is affiliated with Duke University in the United States and has a research focus primarily within the field of Medicine. Their work spans several subfields including Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Statistics and Probability, and Radiology, Nuclear Medicine and Imaging.

The scientist's research concentrates on multiple main topics such as:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Immunotherapy and Biomarkers
  • Statistical Methods in Clinical Trials

Susan Halabi has contributed to a number of scientific papers published in well-known academic journals. Some recent publications include:

  • The Lancet Commission on prostate cancer: planning for the surge in cases, 2024, published in The Lancet
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, published in European Urology
  • Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, 2021, published in Annals of Oncology
  • Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19, 2021, published in JAMA Oncology
  • Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study, 2021, published in Journal of Clinical Oncology

Their frequent co-authors include:

  • Andrew J. Armstrong
  • Elizabeth Garrett-Mayer
  • Richard L. Schilsky
  • Pam K. Mangat
  • Michael J. Morris

Common publication venues where Susan Halabi's work appears are:

  • Journal of Clinical Oncology
  • JCO Precision Oncology
  • Annals of Oncology
  • European Urology
  • UNC Libraries

Award recognition includes being named a Fellow of the American Statistical Association (ASA) in 2015.

Best Publications

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

    Philip W. Kantoff;Susan Halabi;Mark Conaway;Joel Picus

  • Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

    Brian I Rini;Susan Halabi;Jonathan E. Rosenberg;Walter M. Stadler

  • Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

    Brian I. Rini;Susan Halabi;Jonathan E. Rosenberg;Walter M. Stadler

  • Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer

    Susan Halabi;Eric J. Small;Philip W. Kantoff;Michael W. Kattan

  • Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

    Toni K. Choueiri;Susan Halabi;Ben L. Sanford;Olwen Hahn

  • Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

    Eric J. Small;Susan Halabi;Nancy A. Dawson;Walter M. Stadler

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials

    Bernard F. Cole;Richard F. Logan;Susan Halabi;Robert Benamouzig

  • American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma

    Robert A. Kyle;Gary C. Yee;Mark R. Somerfield;Patrick J. Flynn

  • Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663

    Mary-Ellen Taplin;Barur Rajeshkumar;Susan Halabi;Cary P. Werner

  • Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

    Susan Halabi;Chen-Yen Lin;W. Kevin Kelly;Karim S. Fizazi

  • Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

    D. M. Savarese;S. Halabi;V. Hars;W. L. Akerley

  • Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

    Andrew J Armstrong;Susan Halabi;Tim Eisen;Samuel Broderick

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

    William Kevin Kelly;Susan Halabi;Michael Carducci;Daniel George

  • Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

    Susan Halabi;William Kevin Kelly;Hua Ma;Haojin Zhou

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

Frequent Co-Authors

Eric J. Small
Eric J. Small University of California, San Francisco
Daniel J. George
Daniel J. George Duke University
Andrew J. Armstrong
Andrew J. Armstrong Duke University
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Walter M. Stadler
Walter M. Stadler University of Chicago
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Mary-Ellen Taplin
Mary-Ellen Taplin Harvard University
Oliver Sartor
Oliver Sartor Tulane University
Richard L. Schilsky
Richard L. Schilsky University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career paths related to Medicine in the USA often means considering flexible, high-demand healthcare degrees. RN to BSN programs are a popular option for registered nurses seeking to advance their education and unlock broader career opportunities—all with minimal or no in-person clinical requirements.

For those interested in healthcare leadership, finding which online healthcare administration programs have cahme accreditation? is crucial. Accreditation from CAHME ensures program quality and boosts employability for roles in hospital administration and management.

Advanced practice nurses or those seeking executive roles can benefit from online dnp programs. These doctorates often offer flexible, accelerated pathways ideal for working professionals. Additionally, students preferring a more streamlined academic experience may explore dnp programs without dissertation, which can provide a quicker route to the highest clinical nursing qualifications.

Each of these pathways offers unique benefits and can help you tailor your educational journey in healthcare, whether your goal is patient care, leadership, or specialized clinical practice.

Best Scientists Citing Susan Halabi

Trending Scientists

Recently Published Articles